| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/04/2003 | WO2003072700A2 Androgen receptor overexpressing skeletal myoblasts |
| 09/04/2003 | WO2003072698A2 Surface proteins of leptospira |
| 09/04/2003 | WO2003072605A1 Nuclear hormone receptor ligand binding domain-containing protein |
| 09/04/2003 | WO2003072604A1 Transmembrane nfat inhibitory peptide |
| 09/04/2003 | WO2003072603A2 Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours |
| 09/04/2003 | WO2003072602A2 Protein complexes and methods for their use |
| 09/04/2003 | WO2003072601A1 Method for producing hypoallergenic major birch pollen allergens rbet v 1 |
| 09/04/2003 | WO2003072598A2 Hsp70-derived peptides an uses thereof in the diagnosis and treatment of autoimmune diseases |
| 09/04/2003 | WO2003072597A1 Intermediates and methods for making heptapeptide oxytocin analogues |
| 09/04/2003 | WO2003072595A2 Methods and products based on oligomerization of stress proteins |
| 09/04/2003 | WO2003072594A2 An obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity |
| 09/04/2003 | WO2003072591A1 Trpm-2 antisense therapy using an oligonucleotide having 2'-o-(2-methoxyl)ethyl modifications |
| 09/04/2003 | WO2003072195A2 Method for administering glp-1 molecules |
| 09/04/2003 | WO2003072157A1 Immobilized bioactive hydrogel matrices as surface coatings |
| 09/04/2003 | WO2003072155A1 Cross-linked bioactive hydrogel matrices |
| 09/04/2003 | WO2003072131A1 Compositions, test kits and methods for detecting heliobacter pylori |
| 09/04/2003 | WO2003072064A2 Methods and compositions for regulating adipogenesis |
| 09/04/2003 | WO2003072041A2 Assays to monitor amyloid precursor protein processing |
| 09/04/2003 | WO2003072037A2 High-level production of amyloid-beta peptides from imr-32 cells |
| 09/04/2003 | WO2003072035A2 Compositions and methods for the treatment of immune related diseases |
| 09/04/2003 | WO2003072031A2 Treatment of disease by inducing cell apoptosis |
| 09/04/2003 | WO2003072018A2 Ricin vaccine and methods of making and using thereof |
| 09/04/2003 | WO2003071933A2 Novel compositions and methods for cancer |
| 09/04/2003 | WO2003071877A1 Compositions and methods for eliciting an immune response to gram-negative bacterial infections |
| 09/04/2003 | WO2003071860A2 Method for generating maize plants with an increased leaf starch content, and their use for making maize silage |
| 09/04/2003 | WO2003054007A3 Streptococcus antigens |
| 09/04/2003 | WO2003053224A3 Novel compositions and methods for cancer |
| 09/04/2003 | WO2003048334A3 Immunocytokines with modulated selectivity |
| 09/04/2003 | WO2003046566A3 Pedf biopolymer markers predictive of alzheimers disease |
| 09/04/2003 | WO2003046560A3 Self-assembly molecules |
| 09/04/2003 | WO2003046003A3 Plasma protease c1 biopolymer markers predictive of alzheimers disease |
| 09/04/2003 | WO2003045991A3 Complement c3 precursor biopolymer markers predictive of alzheimers disease |
| 09/04/2003 | WO2003040297A3 New protein of the defensin family from oil palm |
| 09/04/2003 | WO2003039438A3 Pna-conjugates for treating chronic myeloid leukaemia (cml) |
| 09/04/2003 | WO2003030922A3 Bestrophin and bestrophin homologous proteins involved in the regulation of energy homeostasis |
| 09/04/2003 | WO2003029778A3 Novel secreted proteins and their uses |
| 09/04/2003 | WO2003029423A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/04/2003 | WO2003029283A3 Genetic sequences related to bone diseases in the osteopetrotic grey-lethal (gl) mouse |
| 09/04/2003 | WO2003025126A3 Compositions and methods for t cell priming and immunotherapy |
| 09/04/2003 | WO2003024999A3 THE F-BOX PROTEIN hCdc4 TARGETS CYCLIN E FOR UBIQUITINYLATION AND DEGRADATION |
| 09/04/2003 | WO2003022867A3 Peptides derived from the superantigen (sag) env protein of herv-k18 and their use in obtaining sag-inhibitory antibodies and in vaccination against sag |
| 09/04/2003 | WO2003018818A3 Method and means for modulating plant cell cycle proteins and their use in plant cell growth control |
| 09/04/2003 | WO2003014151A3 Human secreted proteins, their encoding polynucleotides, and uses thereof |
| 09/04/2003 | WO2003004525A8 Isolation and purification of plasmodium falciparum merozoite protein-142 |
| 09/04/2003 | WO2003003983A3 Receptor agonists useful for the treatment of pain |
| 09/04/2003 | WO2003001212A3 A method for diagnosing a person having multiple sclerosis |
| 09/04/2003 | WO2002103016A3 Human tachykinin-related splice variants and compositions thereof |
| 09/04/2003 | WO2002101080A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 09/04/2003 | WO2002101072A8 Letm1: modulators of cellular proliferation |
| 09/04/2003 | WO2002101069A3 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 09/04/2003 | WO2002101044A3 Brain expressed gene and protein associated with bipolar disorder |
| 09/04/2003 | WO2002101002A3 Identification of snps the hgv-v gene |
| 09/04/2003 | WO2002099107A3 Regulation of human trace amine receptor ta5 |
| 09/04/2003 | WO2002098918A3 Novel targets for a therapeutic intervention in ebv related diseases |
| 09/04/2003 | WO2002096947A3 The lectin-like domain of thrombomodulin and its therapeutic use |
| 09/04/2003 | WO2002094870A8 Proteins and nucleic acids encoding same |
| 09/04/2003 | WO2002089733A3 Recombinant orf2 proteins of the swine hepatitis e virus and their use as a vaccine and as a diagnostic reagent for medical and veterinary applications |
| 09/04/2003 | WO2002083858A8 Methods to inhibit viral replication |
| 09/04/2003 | WO2002083853A3 Method for enhancing the translation and expression of recombinant proteins |
| 09/04/2003 | WO2002081695A3 Genes that are modulated by posttranscriptional gene silencing |
| 09/04/2003 | WO2002079465A3 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto |
| 09/04/2003 | WO2002079248A3 Mammalian alpha-helical protein-53 |
| 09/04/2003 | WO2002079238A3 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis |
| 09/04/2003 | WO2002074923A3 Targets and screens for agents useful in controlling parasitic nematodes |
| 09/04/2003 | WO2002074795A3 Oligomeric complexes of chimeric proteins with enhanced immunogenic potential |
| 09/04/2003 | WO2002070703A3 Cell visual characteristic-modifying sequences |
| 09/04/2003 | WO2002064792A3 Molecules for disease detection and treatment |
| 09/04/2003 | WO2002062823A3 Peptides for facilitating composite receptor expression and translocation of macromolecules |
| 09/04/2003 | WO2002061042A3 Genetic control of organ abscission |
| 09/04/2003 | WO2002061041A3 Solubility reporter gene constructs |
| 09/04/2003 | WO2002060919A3 Molecules with extended half-lives, compositions and uses thereof |
| 09/04/2003 | WO2002059336A3 Cytoplasmic inhibition of gene expression and expression of a foreign protein in a monocot plant by a plant viral vector |
| 09/04/2003 | WO2002059320A3 Dna sequences of escherichia coli cft073 |
| 09/04/2003 | WO2002059313A3 G-protein coupled receptors and nucleic acids encoding same |
| 09/04/2003 | WO2002059152A3 Vr-oac, an osmotically activated channel protein, nucleic acids encoding it, and uses thereof |
| 09/04/2003 | WO2002057436A3 Red blood cell from a transgenic animal as vehicle for polypeptide delivery |
| 09/04/2003 | WO2002055698A3 Transcriptional mediators of blood vessel development and endothelial differentiation |
| 09/04/2003 | WO2002054083A3 Alpha synuclein aggregation assays |
| 09/04/2003 | WO2002050300A3 Human hyperpolarization-activated cyclic nucleotide-gated cation channel hcn3 |
| 09/04/2003 | WO2002047479A3 Cloning bovines by nuclear transplantation |
| 09/04/2003 | WO2002046413A3 Molecules for disease detection and treatment |
| 09/04/2003 | WO2002046389A3 Genes associated with allergic hypersensitivity and mast cell activation |
| 09/04/2003 | WO2002046237A3 Humanized antibodies that recognize beta amyloid peptide |
| 09/04/2003 | WO2002046220A3 Sequences upstream of the carp gene, vectors containing them and uses thereof |
| 09/04/2003 | WO2002045708A3 Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 09/04/2003 | WO2002044331A3 Dap-kinase and hoxa9, two human genes associated with genesis, progression, and aggressiveness of non-small cell lung cancer |
| 09/04/2003 | WO2002038767A3 G protein-coupled receptor protein and nucleic acid molecules and uses therefor |
| 09/04/2003 | WO2002036807A3 Compositions and methods relating to breast specific genes and proteins |
| 09/04/2003 | WO2002036770A3 Polymorphic sequences of the human abca1 gene, their uses, detection methods and kits |
| 09/04/2003 | WO2002034923A9 Monocotyledon plant cells and plants which synthesise modified starch |
| 09/04/2003 | WO2002034042A3 Knockout mice thyroid stimulating hormone receptor (tsh-r) gene |
| 09/04/2003 | WO2002032943A9 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
| 09/04/2003 | WO2002032932A3 Urotensin-ii agonists and antagonists |
| 09/04/2003 | WO2002031166A3 Artificial transcriptional factors and methods of use |
| 09/04/2003 | WO2002024142A3 Use of adenosine receptor modulators for regulating the function of netrines and/or of their receptors |
| 09/04/2003 | WO2002022667A3 Twin-arginine translocation in bacillus |
| 09/04/2003 | WO2002020769A9 Human and mouse targeting peptides identified by phage display |
| 09/04/2003 | WO2002016432A3 Two receptors of meiosis activating sterols designated sam1a and sam1b |
| 09/04/2003 | WO2002016421A9 Altered ospa of borrelia burgdorferi |
| 09/04/2003 | WO2002002808A3 Method and nucleic acids for the analysis of astrocytomas |